Free Trial
OTCMKTS:MCUJF

Medicure (MCUJF) Stock Price, News & Analysis

Medicure logo
$0.70 0.00 (0.00%)
(As of 11/8/2024 ET)

About Medicure Stock (OTCMKTS:MCUJF)

Key Stats

Today's Range
$0.70
$0.70
50-Day Range
$0.63
$0.80
52-Week Range
$0.63
$1.17
Volume
N/A
Average Volume
357 shs
Market Capitalization
$7.27 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market. The company markets and distributes AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company offers Sodium Nitroprusside injection for the reduction of blood pressure for adult and pediatric patients in hypertensive crisis, as well as for producing controlled hypotension to reduce bleeding during surgery, and for the treatment of acute congestive heart failure. It offers products through retail and mail order pharmacies. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada.

Receive MCUJF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medicure and its competitors with MarketBeat's FREE daily newsletter.

MCUJF Stock News Headlines

2025: Digital Asset Insights You Need to Know
As we enter 2025, digital assets are seeing unprecedented growth and interest. In the past year alone, the market capitalization of digital assets has risen by over 20%, capturing the attention of investors worldwide. Our newest guide, "Navigating the Future: A Comprehensive Guide to Digital Assets in 2025," is designed to help you understand how to leverage these dynamic trends and insights for a stronger portfolio.
See More Headlines

MCUJF Stock Analysis - Frequently Asked Questions

Medicure's stock was trading at $0.7754 on January 1st, 2024. Since then, MCUJF shares have decreased by 10.2% and is now trading at $0.6962.
View the best growth stocks for 2024 here
.

Medicure Inc. (OTCMKTS:MCUJF) released its quarterly earnings data on Wednesday, August, 14th. The company reported ($0.09) earnings per share for the quarter. The business had revenue of $3.78 million for the quarter. Medicure had a negative net margin of 12.46% and a negative trailing twelve-month return on equity of 12.72%.

Shares of MCUJF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

Last Earnings
8/14/2024
Today
11/10/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
OTCMKTS:MCUJF
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-680,000.00
Pretax Margin
-12.10%

Debt

Sales & Book Value

Annual Sales
$16.07 million
Cash Flow
$0.09 per share
Book Value
$1.41 per share

Miscellaneous

Free Float
9,090,000
Market Cap
$7.27 million
Optionable
Not Optionable
Beta
1.01
20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

This page (OTCMKTS:MCUJF) was last updated on 11/10/2024 by MarketBeat.com Staff
From Our Partners